YASHVI PATEL: Open Payments
NPI 1891285060 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$95 in 5 payments from 4 companies in 2025. Trend: 2023 $276 · 2024 $281 · 2025 $95
Food & beverage: $95
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 2 | $35 |
| ABBVIE INC. | 1 | $29 |
| Medtronic, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $14 |
Products named: GEMTESA, UBRELVY, INTELLIS ADAPTIVESTIM, MOUNJARO.
Industry payments across TX — which companies pay providers there.
